Michael J. Lenardo

Active 1987–2025

Also published as
Michael J Lenardo
164
Papers
52,111
Citations
110
h-index
160
i10-index

Citations

Citations per year for Michael J. Lenardo1981: 1 citations1987: 4 citations1988: 46 citations1989: 70 citations1990: 180 citations1991: 151 citations1992: 152 citations1993: 197 citations1994: 180 citations1995: 251 citations1996: 257 citations1997: 256 citations1998: 395 citations1999: 462 citations2000: 449 citations2001: 458 citations2002: 499 citations2003: 539 citations2004: 411 citations2005: 486 citations2006: 418 citations2007: 375 citations2008: 382 citations2009: 429 citations2010: 451 citations2011: 448 citations2012: 414 citations2013: 368 citations2014: 414 citations2015: 369 citations2016: 362 citations2017: 376 citations2018: 432 citations2019: 1,155 citations2020: 1,374 citations2021: 1,660 citations2022: 1,282 citations2023: 1,063 citations2024: 1,627 citations2025: 698 citations2026: 15 citations1982–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,118 citing papers, 31.5% of this breakdownChina: 2,844 citing papers, 12.6% of this breakdownGermany: 1,384 citing papers, 6.1% of this breakdownUnited Kingdom: 1,260 citing papers, 5.6% of this breakdownFrance: 929 citing papers, 4.1% of this breakdownJapan: 763 citing papers, 3.4% of this breakdownItaly: 718 citing papers, 3.2% of this breakdownCanada: 717 citing papers, 3.2% of this breakdownAustralia: 554 citing papers, 2.4% of this breakdownSwitzerland: 454 citing papers, 2% of this breakdownSouth Korea: 409 citing papers, 1.8% of this breakdownIndia: 391 citing papers, 1.7% of this breakdown
0%31.5%Other 22.4%

Fields

  • Biochemistry, Genetics and Molecular Biology34.3%
  • Medicine33.5%
  • Immunology and Microbiology24.5%
  • Neuroscience2.1%
  • Engineering1.2%
  • Nursing1.1%
  • Other3.3%

Topics

  • Immune Cell Function and Interaction5.7%
  • T-cell and B-cell Immunology4%
  • Cell death mechanisms and regulation3.8%
  • NF-κB Signaling Pathways3.6%
  • Immunotherapy and Immune Responses3.4%
  • Autophagy in Disease and Therapy3.3%
  • Other76.2%

Coauthors

All papers

Open in search
  1. A guide to cancer immunotherapy: from T cell basic science to clinical practice

    Authors: , , - Nature reviews. Immunology 2020 cited by 4,146

  2. 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology

    Authors: , , - Cell 2017 cited by 2,072

  3. Mucus sialylation determines intestinal host-commensal homeostasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Oellerich, Stacy A. Malaker, Lixin Zheng, Carolyn R. Bertozzi, Yu Zhang, Helen Matthews, Will Montgomery, Han‐Yu Shih, Jiansheng Jiang, Marcus B. Jones, Aris Baras, Alan R. Shuldiner, Claudia Gonzaga‐Jauregui, Scott B. Snapper, Aleixo M. Muise, Dror S. Shouval, Ahmet Özen, Kuan‐Ting Pan, Chuan Wu, Michael J. Lenardo - Cell 2022 cited by 243

  4. Termination of autophagy and reformation of lysosomes regulated by mTOR

    Authors: , , , , , , , , , , , , , , - Nature 2010 cited by 1,574

  5. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrine Hall, Hongying Wang, Jae Jin Chae, Natalia I. Dmitrieva, Mark McKenzie, Amanda Light, Beverly Barham, Anne Jones, Tina Romeo, Qing Zhou, Ivona Aksentijevich, James C. Mullikin, Andrew J. Gross, Anthony K. Shum, Edwin D. Hawkins, Seth L. Masters, Michael J. Lenardo, Manfred Boehm, Sergio D. Rosenzweig, Manolis Pasparakis, Anne K. Voss, Massimo Gadina, Daniel L. Kastner, John Silke - Nature 2019 cited by 333

  6. The TNF and TNF Receptor Superfamilies

    Authors: , , - Cell 2001 cited by 3,616

  7. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Meffre, Thomas A. Fleisher, Steven M. Holland, Michael J. Lenardo, Stuart G. Tangye, Gülbû Uzel - Science 2014 cited by 855

  8. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells

    Authors: , , , , - Nature Immunology 2007 cited by 1,221

  9. A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 132

  10. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , V. Koneti Rao, Michael J. Lenardo, Michael B. Jordan - Science 2015 cited by 691

  11. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2013 cited by 664

  12. Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 286

  13. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency

    Authors: , , , , , , , , , - Nature 2011 cited by 540

  14. The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives

    Authors: , - Cell Research 2009 cited by 367

  15. Mg 2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2013 cited by 337

  16. CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen C. Su, Kaan Boztuǧ, Michael J. Lenardo - New England Journal of Medicine 2017 cited by 199

  17. Autophagic programmed cell death by selective catalase degradation

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 661

  18. A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling

    Authors: , , , , , - Science 2000 cited by 848

  19. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

    Authors: , , , , , , , , , , - Blood 2010 cited by 486

  20. Mitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis

    Authors: , , , , , , , - PLoS ONE 2016 cited by 158

  21. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

    Authors: , , , , , , , , - Cell 1995 cited by 1,471

  22. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 285

  23. Development of immune checkpoint therapy for cancer

    Authors: , - The Journal of Experimental Medicine 2019 cited by 179

  24. Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder

    Authors: , , , , , , , , , - Nature Communications 2014 cited by 175